El-BalatA, DeWildeRL, SchmeilI, et al.Modern myoma treatment in the last 20 years: A review of the literature. Biomed Res Int, 2018; 2018:4593875; doi: 10.1155/2018/4593875
3.
Bulletins–Gynecology ACoOaGCoP. Management of symptomatic uterine leiomyomas: ACOG practice bulletin, number 228. Obstet Gynecol, 2021; 137(6):e100–e115; doi: 10.1097/aog.0000000000004401
4.
TemplemanC, MarshallSF, ClarkeCA, et al.Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril, 2009; 92(4):1436–1446; doi: 10.1016/j.fertnstert.2008.08.074
5.
StewartEA, CooksonCL, GandolfoRA, et al.Epidemiology of uterine fibroids: A systematic review. Bjog, 2017; 124(10):1501–1512; doi: 10.1111/1471-0528.14640
6.
WilcoxLS, KooninLM, PokrasR, et al.Hysterectomy in the United States, 1988–1990. Obstet Gynecol, 1994; 83(4):549–555; doi: 10.1097/00006250-199404000-00011
7.
MeilahnEN, MatthewsKA, EgelandG, et al.Characteristics of women with hysterectomy. Maturitas, 1989; 11(4):319–329; doi: 10.1016/0378-5122(89)90028-5
8.
BrettKM, MarshJV, MadansJH. Epidemiology of hysterectomy in the United States: Demographic and reproductive factors in a nationally representative sample. J Womens Health, 1997; 6(3):309–316; doi: 10.1089/jwh.1997.6.309
9.
PavoneD, ClemenzaS, SorbiF, et al.Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol, 2018; 46:3–11; doi: 10.1016/j.bpobgyn.2017.09.004
10.
KoebeleSV, PalmerJM, HadderB, et al.Hysterectomy uniquely impacts spatial memory in a rat model: A role for the nonpregnant uterus in cognitive processes. Endocrinology, 2019; 160(1):1–19; doi: 10.1210/en.2018-00709
11.
TuesleyKM, ProtaniMM, WebbPM, et al.Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality. Am J Obstet Gynecol, 2020; 223(5):723.e1–723.e16; doi: 10.1016/j.ajog.2020.04.037
12.
BairdDD, DunsonDB, HillMC, et al.High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol, 2003; 188(1):100–107; doi: 10.1067/mob.2003.99
13.
EltoukhiHM, ModiMN, WestonM, et al.The health disparities of uterine fibroid tumors for African American women: A public health issue. Am J Obstet Gynecol, 2014; 210(3):194–199; doi: 10.1016/j.ajog.2013.08.008
14.
Laughlin-TommasoSK, JacobyVL, MyersER. Disparities in fibroid incidence, prognosis, and management. Obstet Gynecol Clin North Am, 2017; 44(1):81–94; doi: 10.1016/j.ogc.2016.11.007
15.
StewartEA, NicholsonWK, BradleyL, et al.The burden of uterine fibroids for African-American women: Results of a national survey. J Womens Health (Larchmt), 2013; 22(10):807–816; doi: 10.1089/jwh.2013.4334
16.
StewartEA, LytleBL, ThomasL, et al.The comparing options for management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: Rationale and design. Am J Obstet Gynecol, 2018; 219(1):95.e1–95.e10; doi: 10.1016/j.ajog.2018.05.004
17.
HeY, ZengQ, DongS, et al.Associations between uterine fibroids and lifestyles including diet, physical activity and stress: A case-control study in China. Asia Pac J Clin Nutr, 2013; 22(1):109–117; doi: 10.6133/apjcn.2013.22.1.07
